The goals of the REMS are:

• To mitigate the occurrence and morbidity associated with meningococcal infections

• To educate Healthcare Professionals (HCPs) and Patients regarding:

      - the increased risk of meningococcal infections with Soliris

      - the early signs of invasive meningococcal infections, and

      - the need for immediate medical evaluation of signs and symptoms consistent with possible meningococcal infections